Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Merck
AstraZeneca
Deloitte
Julphar
Cipla
Queensland Health

Generated: June 26, 2019

DrugPatentWatch Database Preview

Details for Patent: 4,971,998

Try a free trialSee Plans and Pricing

« Back to Dashboard

Summary for Patent: 4,971,998
Title: Methods for treating the premenstrual or late luteal phase syndrome
Abstract:Compositions useful in the treatment of disturbances of appetite, disturbances of mood, or both, associated with premenstrual syndrome, as well as methods of use therefor. The compositions include serotoninergic drugs, such as d-fenfluramine and fluoxetine.
Inventor(s): Wurtman; Richard J. (Boston, MA), Wurtman; Judith J. (Boston, MA)
Assignee: Massachusetts Institute of Technology (Cambridge, MA)
Application Number:07/244,944
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 4,971,998
Prior Art and Litigation SupportOrder Prior Art and Litigation support for Patent 4,971,998
Patent Claim Types:
see list of patent claims
Use; Composition;

Drugs Protected by US Patent 4,971,998

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Express Scripts
US Department of Justice
Moodys
McKinsey
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.